Steve Pascolo (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Steve Pascolo" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

28nih.gov

4^th place

8^th place

21doi.org

2^nd place

4^th place

4worldcat.org

5^th place

1wikipedia.org

low place

1uzh.ch

3,633^rd place

low place

1researchgate.net

120^th place

157^th place

1lexpress.fr

425^th place

2,111^th place

1wipo.int

1,462^nd place

2,056^th place

1arte.tv

1,950^th place

low place

1sciencedirect.com

149^th place

155^th place

1nature.com

234^th place

190^th place

1frontiersin.org

4,679^th place

3,123^rd place

1plos.org

2,112^th place

848^th place

1srf.ch

1,487^th place

low place

1bfmtv.com

590^th place

4,212^th place

1rts.ch

2,352^nd place

5,847^th place

1books.google.com

3^rd place

6^th place

1oup.com

485^th place

414^th place

arte.tv

«O RNA do mensageiro pode curar o cancro?»

bfmtv.com

«AstraZeneca, les premières doses injectées - 06/02» – via www.bfmtv.com

books.google.com

Genomic and Personalized Medicine (em inglês). [S.l.]: Academic Press. 11 de novembro de 2008. ISBN 9780080919034

doi.org

dx.doi.org

Hoerr, I.; Obst, R.; Rammensee, H. G.; Jung, G. (17 de janeiro de 2000). «In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies». European Journal of Immunology. 30 (1): 1–7. PMID 10602021. doi:10.1002/1521-4141(200001)30:1<1::AID-IMMU1>3.0.CO;2-# – via PubMed
Martinon, F.; Krishnan, S.; Lenzen, G.; Magné, R.; Gomard, E.; Guillet, J. G.; Lévy, J. P.; Meulien, P. (1993). «Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA». European Journal of Immunology. 23 (7): 1719–1722. PMID 8325342. doi:10.1002/eji.1830230749
Probst, J.; Weide, B.; Scheel, B.; Pichler, B. J.; Hoerr, I.; Rammensee, H.-G.; Pascolo, S. (17 de agosto de 2007). «Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent». Gene Therapy. 14 (15): 1175–1180. PMID 17476302. doi:10.1038/sj.gt.3302964 – via PubMed
Weide, B.; Carralot, J. P.; Reese, A.; Scheel, B.; Eigentler, T. K.; Hoerr, I.; Rammensee, H. G.; Garbe, C.; Pascolo, S. (2008). «Results of the first phase I/II clinical vaccination trial with direct injection of mRNA». Journal of Immunotherapy (Hagerstown, Md. : 1997). 31 (2): 180–188. PMID 18481387. doi:10.1097/CJI.0b013e31815ce501
Weide, Benjamin; Pascolo, Steve; Scheel, Birgit; Derhovanessian, Evelyna; Pflugfelder, Annette; Eigentler, Thomas K.; Pawelec, Graham; Hoerr, Ingmar; Rammensee, Hans-Georg; Garbe, Claus (17 de junho de 2009). «Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients». Journal of Immunotherapy (Hagerstown, Md.: 1997). 32 (5): 498–507. PMID 19609242. doi:10.1097/CJI.0b013e3181a00068 – via PubMed
Rittig, Susanne M.; Haentschel, Maik; Weimer, Katrin J.; Heine, Annkristin; Muller, Martin R.; Brugger, Wolfram; Horger, Marius S.; Maksimovic, Olga; Stenzl, Arnulf; Hoerr, Ingmar; Rammensee, Hans-Georg; Holderried, Tobias A. W.; Kanz, Lothar; Pascolo, Steve; Brossart, Peter (17 de maio de 2011). «Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients». Molecular Therapy: The Journal of the American Society of Gene Therapy. 19 (5): 990–999. PMC 3098631. PMID 21189474. doi:10.1038/mt.2010.289 – via PubMed
Pascolo, Steve (15 de janeiro de 2016). «Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies». European Journal of Pharmacology. 771: 139–144. PMID 26687632. doi:10.1016/j.ejphar.2015.12.017 – via www.sciencedirect.com
Pardi, Norbert; Hogan, Michael J.; Porter, Frederick W.; Weissman, Drew (17 de abril de 2018). «mRNA vaccines — a new era in vaccinology». Nature Reviews Drug Discovery. 17 (4): 261–279. PMC 5906799. PMID 29326426. doi:10.1038/nrd.2017.243 – via www.nature.com
Zhang, Cuiling; Maruggi, Giulietta; Shan, Hu; Li, Junwei (17 de abril de 2019). «Advances in mRNA Vaccines for Infectious Diseases». Frontiers in Immunology. 10: 594. PMC 6446947. PMID 30972078. doi:10.3389/fimmu.2019.00594 – via Frontiers
Schnee, Margit; Vogel, Annette B.; Voss, Daniel; Petsch, Benjamin; Baumhof, Patrick; Kramps, Thomas; Stitz, Lothar (23 de junho de 2016). «An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs». PLOS Neglected Tropical Diseases. 10 (6): e0004746. PMC 4918980. PMID 27336830. doi:10.1371/journal.pntd.0004746 – via PLoS Journals
Pascolo, Steve (9 de fevereiro de 2021). «Synthetic Messenger RNA-Based Vaccines: from Scorn to Hype». Viruses. 13 (2): 270. PMC 7916233. PMID 33572452. doi:10.3390/v13020270 – via PubMed
Pascolo, Steve (2013). «Enhancement of Gene Gun-Induced Vaccine-Specific Cytotoxic T-Cell Response by Administration of Chemotherapeutic Drugs». In: Sudowe, Stephan; Reske-Kunz, Angelika B. Biolistic DNA Delivery. Biolistic DNA Delivery: Methods and Protocols. Col: Methods in Molecular Biology (em inglês). 940. [S.l.]: Humana Press. pp. 189–198. ISBN 9781627031103. PMID 23104344. doi:10.1007/978-1-62703-110-3_16
Pascolo, Steve (2008), «Vaccination with Messenger RNA (mRNA)», in: Bauer, Stefan; Hartmann, Gunther, Toll-Like Receptors (TLRS) and Innate Immunity, ISBN 9783540721673, Handbook of Experimental Pharmacology (em inglês), 183 (183), Springer Berlin Heidelberg, pp. 221–235, PMID 18071662, doi:10.1007/978-3-540-72167-3_11
Pascolo, Steve (2006), «Plasmid DNA and Messenger RNA for Therapy», Handbook of Pharmaceutical Biotechnology, ISBN 9780470117118 (em inglês), John Wiley & Sons, Ltd, pp. 971–1011, doi:10.1002/9780470117118.ch07b
Pascolo, Steve (2005), «RNA-Based Therapies», Drug Discovery Handbook, ISBN 9780471728788 (em inglês), John Wiley & Sons, Ltd, pp. 1259–1308, doi:10.1002/0471728780.ch27
Pascolo, Steve (15 de janeiro de 2016). «Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies». European Journal of Pharmacology. 771: 139–144. ISSN 0014-2999. PMID 26687632. doi:10.1016/j.ejphar.2015.12.017
Pascolo, Steve (17 de fevereiro de 2015). «The messenger's great message for vaccination». Expert Review of Vaccines. 14 (2): 153–156. PMID 25586101. doi:10.1586/14760584.2015.1000871 – via PubMed
Pascolo, S. (18 de agosto de 2011). «Commenting on communicator RNA». Gene Therapy (em inglês). 18 (10): 943–944. ISSN 1476-5462. PMID 21850049. doi:10.1038/gt.2011.122
Pascolo, Steve (1 de julho de 2005). «HLA class I transgenic mice: development, utilisation and improvement». Expert Opinion on Biological Therapy. 5 (7): 919–938. ISSN 1471-2598. PMID 16018738. doi:10.1517/14712598.5.7.919
Rammensee, Hans-Georg; Lemonnier, Francois A.; Ehrlich, Rachel; Danos, Olivier; Fisch, Paul; Obermayr, Florian; Rohrlich, Pierre; Probst, Jochen; Schoor, Oliver (1 de fevereiro de 2005). «The non-classical HLA class I molecule HFE does not influence the NK-like activity contained in fresh human PBMCs and does not interact with NK cells». International Immunology (em inglês). 17 (2): 117–122. ISSN 0953-8178. PMID 15623549. doi:10.1093/intimm/dxh191
Pascolo, Steve (17 de agosto de 2004). «Messenger RNA-based vaccines». Expert Opinion on Biological Therapy. 4 (8): 1285–1294. PMID 15268662. doi:10.1517/14712598.4.8.1285 – via PubMed

frontiersin.org

Zhang, Cuiling; Maruggi, Giulietta; Shan, Hu; Li, Junwei (17 de abril de 2019). «Advances in mRNA Vaccines for Infectious Diseases». Frontiers in Immunology. 10: 594. PMC 6446947. PMID 30972078. doi:10.3389/fimmu.2019.00594 – via Frontiers

lexpress.fr

«Ingmar Hoerr, cofondateur de CureVac : "Notre vaccin sera moins cher et plus accessible"». LExpress.fr. 12 de março de 2021

nature.com

Pardi, Norbert; Hogan, Michael J.; Porter, Frederick W.; Weissman, Drew (17 de abril de 2018). «mRNA vaccines — a new era in vaccinology». Nature Reviews Drug Discovery. 17 (4): 261–279. PMC 5906799. PMID 29326426. doi:10.1038/nrd.2017.243 – via www.nature.com

nih.gov

ncbi.nlm.nih.gov

Hoerr, I.; Obst, R.; Rammensee, H. G.; Jung, G. (17 de janeiro de 2000). «In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies». European Journal of Immunology. 30 (1): 1–7. PMID 10602021. doi:10.1002/1521-4141(200001)30:1<1::AID-IMMU1>3.0.CO;2-# – via PubMed
Martinon, F.; Krishnan, S.; Lenzen, G.; Magné, R.; Gomard, E.; Guillet, J. G.; Lévy, J. P.; Meulien, P. (1993). «Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA». European Journal of Immunology. 23 (7): 1719–1722. PMID 8325342. doi:10.1002/eji.1830230749
Probst, J.; Weide, B.; Scheel, B.; Pichler, B. J.; Hoerr, I.; Rammensee, H.-G.; Pascolo, S. (17 de agosto de 2007). «Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent». Gene Therapy. 14 (15): 1175–1180. PMID 17476302. doi:10.1038/sj.gt.3302964 – via PubMed
Weide, B.; Carralot, J. P.; Reese, A.; Scheel, B.; Eigentler, T. K.; Hoerr, I.; Rammensee, H. G.; Garbe, C.; Pascolo, S. (2008). «Results of the first phase I/II clinical vaccination trial with direct injection of mRNA». Journal of Immunotherapy (Hagerstown, Md. : 1997). 31 (2): 180–188. PMID 18481387. doi:10.1097/CJI.0b013e31815ce501
Weide, Benjamin; Pascolo, Steve; Scheel, Birgit; Derhovanessian, Evelyna; Pflugfelder, Annette; Eigentler, Thomas K.; Pawelec, Graham; Hoerr, Ingmar; Rammensee, Hans-Georg; Garbe, Claus (17 de junho de 2009). «Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients». Journal of Immunotherapy (Hagerstown, Md.: 1997). 32 (5): 498–507. PMID 19609242. doi:10.1097/CJI.0b013e3181a00068 – via PubMed
Rittig, Susanne M.; Haentschel, Maik; Weimer, Katrin J.; Heine, Annkristin; Muller, Martin R.; Brugger, Wolfram; Horger, Marius S.; Maksimovic, Olga; Stenzl, Arnulf; Hoerr, Ingmar; Rammensee, Hans-Georg; Holderried, Tobias A. W.; Kanz, Lothar; Pascolo, Steve; Brossart, Peter (17 de maio de 2011). «Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients». Molecular Therapy: The Journal of the American Society of Gene Therapy. 19 (5): 990–999. PMC 3098631. PMID 21189474. doi:10.1038/mt.2010.289 – via PubMed
Pascolo, Steve (15 de janeiro de 2016). «Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies». European Journal of Pharmacology. 771: 139–144. PMID 26687632. doi:10.1016/j.ejphar.2015.12.017 – via www.sciencedirect.com
Pardi, Norbert; Hogan, Michael J.; Porter, Frederick W.; Weissman, Drew (17 de abril de 2018). «mRNA vaccines — a new era in vaccinology». Nature Reviews Drug Discovery. 17 (4): 261–279. PMC 5906799. PMID 29326426. doi:10.1038/nrd.2017.243 – via www.nature.com
Zhang, Cuiling; Maruggi, Giulietta; Shan, Hu; Li, Junwei (17 de abril de 2019). «Advances in mRNA Vaccines for Infectious Diseases». Frontiers in Immunology. 10: 594. PMC 6446947. PMID 30972078. doi:10.3389/fimmu.2019.00594 – via Frontiers
Schnee, Margit; Vogel, Annette B.; Voss, Daniel; Petsch, Benjamin; Baumhof, Patrick; Kramps, Thomas; Stitz, Lothar (23 de junho de 2016). «An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs». PLOS Neglected Tropical Diseases. 10 (6): e0004746. PMC 4918980. PMID 27336830. doi:10.1371/journal.pntd.0004746 – via PLoS Journals
Pascolo, Steve (9 de fevereiro de 2021). «Synthetic Messenger RNA-Based Vaccines: from Scorn to Hype». Viruses. 13 (2): 270. PMC 7916233. PMID 33572452. doi:10.3390/v13020270 – via PubMed
Pascolo, Steve (2013). «Enhancement of Gene Gun-Induced Vaccine-Specific Cytotoxic T-Cell Response by Administration of Chemotherapeutic Drugs». In: Sudowe, Stephan; Reske-Kunz, Angelika B. Biolistic DNA Delivery. Biolistic DNA Delivery: Methods and Protocols. Col: Methods in Molecular Biology (em inglês). 940. [S.l.]: Humana Press. pp. 189–198. ISBN 9781627031103. PMID 23104344. doi:10.1007/978-1-62703-110-3_16
Pascolo, Steve (2008), «Vaccination with Messenger RNA (mRNA)», in: Bauer, Stefan; Hartmann, Gunther, Toll-Like Receptors (TLRS) and Innate Immunity, ISBN 9783540721673, Handbook of Experimental Pharmacology (em inglês), 183 (183), Springer Berlin Heidelberg, pp. 221–235, PMID 18071662, doi:10.1007/978-3-540-72167-3_11
Pascolo, Steve (15 de janeiro de 2016). «Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies». European Journal of Pharmacology. 771: 139–144. ISSN 0014-2999. PMID 26687632. doi:10.1016/j.ejphar.2015.12.017
Pascolo, Steve (17 de fevereiro de 2015). «The messenger's great message for vaccination». Expert Review of Vaccines. 14 (2): 153–156. PMID 25586101. doi:10.1586/14760584.2015.1000871 – via PubMed
Pascolo, S. (18 de agosto de 2011). «Commenting on communicator RNA». Gene Therapy (em inglês). 18 (10): 943–944. ISSN 1476-5462. PMID 21850049. doi:10.1038/gt.2011.122
Pascolo, Steve (1 de julho de 2005). «HLA class I transgenic mice: development, utilisation and improvement». Expert Opinion on Biological Therapy. 5 (7): 919–938. ISSN 1471-2598. PMID 16018738. doi:10.1517/14712598.5.7.919
Rammensee, Hans-Georg; Lemonnier, Francois A.; Ehrlich, Rachel; Danos, Olivier; Fisch, Paul; Obermayr, Florian; Rohrlich, Pierre; Probst, Jochen; Schoor, Oliver (1 de fevereiro de 2005). «The non-classical HLA class I molecule HFE does not influence the NK-like activity contained in fresh human PBMCs and does not interact with NK cells». International Immunology (em inglês). 17 (2): 117–122. ISSN 0953-8178. PMID 15623549. doi:10.1093/intimm/dxh191
Pascolo, Steve (17 de agosto de 2004). «Messenger RNA-based vaccines». Expert Opinion on Biological Therapy. 4 (8): 1285–1294. PMID 15268662. doi:10.1517/14712598.4.8.1285 – via PubMed

pubmed.ncbi.nlm.nih.gov

Hoerr, I.; Obst, R.; Rammensee, H. G.; Jung, G. (17 de janeiro de 2000). «In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies». European Journal of Immunology. 30 (1): 1–7. PMID 10602021. doi:10.1002/1521-4141(200001)30:1<1::AID-IMMU1>3.0.CO;2-# – via PubMed
Martinon, F.; Krishnan, S.; Lenzen, G.; Magné, R.; Gomard, E.; Guillet, J. G.; Lévy, J. P.; Meulien, P. (1993). «Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA». European Journal of Immunology. 23 (7): 1719–1722. PMID 8325342. doi:10.1002/eji.1830230749
Probst, J.; Weide, B.; Scheel, B.; Pichler, B. J.; Hoerr, I.; Rammensee, H.-G.; Pascolo, S. (17 de agosto de 2007). «Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent». Gene Therapy. 14 (15): 1175–1180. PMID 17476302. doi:10.1038/sj.gt.3302964 – via PubMed
Weide, B.; Carralot, J. P.; Reese, A.; Scheel, B.; Eigentler, T. K.; Hoerr, I.; Rammensee, H. G.; Garbe, C.; Pascolo, S. (2008). «Results of the first phase I/II clinical vaccination trial with direct injection of mRNA». Journal of Immunotherapy (Hagerstown, Md. : 1997). 31 (2): 180–188. PMID 18481387. doi:10.1097/CJI.0b013e31815ce501
Weide, Benjamin; Pascolo, Steve; Scheel, Birgit; Derhovanessian, Evelyna; Pflugfelder, Annette; Eigentler, Thomas K.; Pawelec, Graham; Hoerr, Ingmar; Rammensee, Hans-Georg; Garbe, Claus (17 de junho de 2009). «Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients». Journal of Immunotherapy (Hagerstown, Md.: 1997). 32 (5): 498–507. PMID 19609242. doi:10.1097/CJI.0b013e3181a00068 – via PubMed
Rittig, Susanne M.; Haentschel, Maik; Weimer, Katrin J.; Heine, Annkristin; Muller, Martin R.; Brugger, Wolfram; Horger, Marius S.; Maksimovic, Olga; Stenzl, Arnulf; Hoerr, Ingmar; Rammensee, Hans-Georg; Holderried, Tobias A. W.; Kanz, Lothar; Pascolo, Steve; Brossart, Peter (17 de maio de 2011). «Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients». Molecular Therapy: The Journal of the American Society of Gene Therapy. 19 (5): 990–999. PMC 3098631. PMID 21189474. doi:10.1038/mt.2010.289 – via PubMed
Pascolo, Steve (9 de fevereiro de 2021). «Synthetic Messenger RNA-Based Vaccines: from Scorn to Hype». Viruses. 13 (2): 270. PMC 7916233. PMID 33572452. doi:10.3390/v13020270 – via PubMed
Pascolo, Steve (17 de fevereiro de 2015). «The messenger's great message for vaccination». Expert Review of Vaccines. 14 (2): 153–156. PMID 25586101. doi:10.1586/14760584.2015.1000871 – via PubMed
Pascolo, Steve (17 de agosto de 2004). «Messenger RNA-based vaccines». Expert Opinion on Biological Therapy. 4 (8): 1285–1294. PMID 15268662. doi:10.1517/14712598.4.8.1285 – via PubMed

oup.com

academic.oup.com

Rammensee, Hans-Georg; Lemonnier, Francois A.; Ehrlich, Rachel; Danos, Olivier; Fisch, Paul; Obermayr, Florian; Rohrlich, Pierre; Probst, Jochen; Schoor, Oliver (1 de fevereiro de 2005). «The non-classical HLA class I molecule HFE does not influence the NK-like activity contained in fresh human PBMCs and does not interact with NK cells». International Immunology (em inglês). 17 (2): 117–122. ISSN 0953-8178. PMID 15623549. doi:10.1093/intimm/dxh191

plos.org

journals.plos.org

Schnee, Margit; Vogel, Annette B.; Voss, Daniel; Petsch, Benjamin; Baumhof, Patrick; Kramps, Thomas; Stitz, Lothar (23 de junho de 2016). «An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs». PLOS Neglected Tropical Diseases. 10 (6): e0004746. PMC 4918980. PMID 27336830. doi:10.1371/journal.pntd.0004746 – via PLoS Journals

researchgate.net

https://www.researchgate.net/publication/333456052_Design_of_in_vitro_Transcribed_mRNA_Vectors_for_Research_and_Therapy

rts.ch

«Play RTS». Play RTS

sciencedirect.com

Pascolo, Steve (15 de janeiro de 2016). «Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies». European Journal of Pharmacology. 771: 139–144. PMID 26687632. doi:10.1016/j.ejphar.2015.12.017 – via www.sciencedirect.com

srf.ch

«10 vor 10 vom 05.02.2021 - Play SRF» – via www.srf.ch

uzh.ch

cancer.uzh.ch

«PD Dr. Steve Pascolo». www.cancer.uzh.ch

wikipedia.org

en.wikipedia.org

«CureVac». 28 de março de 2021 – via Wikipedia

wipo.int

patentscope.wipo.int

«Immunogenic Preparations and Vaccines on the Basis of Mrna»

worldcat.org

Pascolo, Steve (15 de janeiro de 2016). «Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies». European Journal of Pharmacology. 771: 139–144. ISSN 0014-2999. PMID 26687632. doi:10.1016/j.ejphar.2015.12.017
Pascolo, S. (18 de agosto de 2011). «Commenting on communicator RNA». Gene Therapy (em inglês). 18 (10): 943–944. ISSN 1476-5462. PMID 21850049. doi:10.1038/gt.2011.122
Pascolo, Steve (1 de julho de 2005). «HLA class I transgenic mice: development, utilisation and improvement». Expert Opinion on Biological Therapy. 5 (7): 919–938. ISSN 1471-2598. PMID 16018738. doi:10.1517/14712598.5.7.919
Rammensee, Hans-Georg; Lemonnier, Francois A.; Ehrlich, Rachel; Danos, Olivier; Fisch, Paul; Obermayr, Florian; Rohrlich, Pierre; Probst, Jochen; Schoor, Oliver (1 de fevereiro de 2005). «The non-classical HLA class I molecule HFE does not influence the NK-like activity contained in fresh human PBMCs and does not interact with NK cells». International Immunology (em inglês). 17 (2): 117–122. ISSN 0953-8178. PMID 15623549. doi:10.1093/intimm/dxh191